Fundraising FoxAllergen Research
San Mateo, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Allergen Research
Sign up to see every warm intro you have to Allergen Research
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allergen Research team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
VC
Victor ColungaExecutive
SG
Stephen G. Dilly, Jr.Executive
Board
Investors · 4
Longitude CapitalreportedMenlo Park · $10M – $30M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$334.7M disclosed across 3 rounds · 2015–2018
▶$98MraisedNov 2018 · 1 investors · Other Health CareRule 506(b)
▶$98MraisedNov 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric H. BjerkholtExecutive Officer
- Mark D. McDadeDirector
- Patrick G. EnrightDirector
- Brett K. HaumannDirector
- Daniel C. AdelmanExecutive Officer
- Mary M. RozenmanExecutive Officer
- Susan E. BarrowcliffeExecutive Officer
- Douglas T. SheehyExecutive Officer
- Stacey D. SeltzerDirector
- Gregory BeharDirector
- Jayson D.A. DallasExecutive Officer, Director
- Kathryn E. FalbergDirector
- Mark T. IwickiDirector
- Offering amount
- $98M
- Amount sold
- $98M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$156.7MraisedMar 2018 · 2 investors · Other Health CareRule 506(b)
▶$156.7MraisedMar 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark D. McDadeDirector
- Kathryn E. FalbergDirector
- Jeffrey H. KnappExecutive Officer
- Patrick G. EnrightDirector
- Daniel C. AdelmanExecutive Officer
- Susan E. BarrowcliffeExecutive Officer
- Stephen G. Dilly, Jr.Executive Officer, Director
- Gregory BeharDirector
- Mark T. IwickiDirector
- Mary M. RozenmanExecutive Officer
- Stacey D. SeltzerDirector
- Eric H. BjerkholtExecutive Officer
- Douglas T. SheehyExecutive Officer
- Offering amount
- $156.7M
- Amount sold
- $156.7M
- Minimum investment
- $1
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$80MraisedMar 2015 · 10 investors · Other Health CareRule 506(b)
▶$80MraisedMar 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joonkyoo (Anthony) YunDirector
- Stacey D. SeltzerDirector
- James TananbaumDirector
- Victor ColungaExecutive Officer
- Bryan L. WalserDirector
- Stephen G. Dilly, Jr.Executive Officer, Director
- Patrick EnrightDirector
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Allergen Research's investors?
- Allergen Research's investors include Aisling Capital, Foresite Capital, Longitude Capital, Qiming Healthcare.
- How much funding has Allergen Research raised?
- Allergen Research has disclosed $334.7M raised across 3 rounds.
- Where is Allergen Research headquartered?
- Allergen Research is headquartered in San Mateo, US.